Amitiza (Takeda Pharmaceuticals America, Inc.)


Welcome to the PulseAid listing for the Amitiza drug offered from Takeda Pharmaceuticals America, Inc.. This Chloride Channel Activator [EPC],Chloride Channel Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Takeda Pharmaceuticals America, Inc.
NON-PROPRIETARY NAME: lubiprostone
SUBSTANCE NAME: LUBIPROSTONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Chloride Channel Activator [EPC],Chloride Channel Activators [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-01-31
END MARKETING DATE: 0000-00-00


Amitiza HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAmitiza from Takeda Pharmaceuticals America, Inc.
LABELER NAME: Takeda Pharmaceuticals America, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8(ug/1)
START MARKETING DATE: 2006-01-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64764-080_25bf735c-04fe-4067-8108-21956899b68b
PRODUCT NDC: 64764-080
APPLICATION NUMBER: NDA021908

Other LUBIPROSTONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalAmitiza
Bryant Ranch PrepackAmitiza
Carilion Materials ManagementAmitiza
Lake Erie Medical DBA Quality Care Products LLCAmitiza
Physicians Total Care, Inc.Amitiza
STAT RX USA LLCAMITIZA
Takeda Pharmaceuticals America, Inc.Amitiza